EVO ICL PHAKIC IOL SURGERY SUITABILITY SCREENING

EVO ICL phakic intraocular lens surgery suitability screening is a comprehensive eye evaluation that determines whether you qualify for EVO Implantable Collamer Lens vision correction. This screening focuses on safety, predictability, and long-term eye health. Unlike laser vision correction, EVO ICL works by placing a biocompatible lens inside the eye while your natural lens remains in place. Therefore, precise measurements and risk checks are essential before surgery.

WHO SHOULD CONSIDER EVO ICL SCREENING

You may benefit from EVO ICL screening if you have moderate to very high nearsightedness, with or without astigmatism, and you are not an ideal candidate for LASIK or SMILE. In addition, patients with thin corneas or dry eyes often explore this option. However, proper screening must confirm that your eye anatomy supports safe lens implantation.

WHAT THE SCREENING INCLUDES

This structured assessment uses evidence-based diagnostic tests and follows international refractive surgery guidelines. First, your doctor reviews your medical and eye history. Next, advanced instruments measure key structures of your eye. These tests typically include:

1. Detailed refraction and cycloplegic refraction
2. Corneal topography and tomography mapping
3. Anterior chamber depth measurement
4. Endothelial cell count
5. White-to-white and sulcus size estimation
6. Intraocular pressure check
7. Dilated retinal examination

Together, these results guide lens sizing and risk assessment. As a result, your surgeon can recommend whether EVO ICL is appropriate or whether another option is safer.

SAFETY AND MEDICAL BASIS

Modern EVO ICL lenses use a collagen-based material designed for long-term compatibility inside the eye. Clinical studies show strong visual outcomes and high patient satisfaction when proper screening and sizing occur. Moreover, screening helps reduce the risk of complications such as high eye pressure, cataract formation, or improper lens vault. For this reason, surgeons follow strict inclusion and exclusion criteria.

WHY SCREENING MATTERS

Not every patient who wants EVO ICL should receive it. For example, shallow anterior chambers, low endothelial cell counts, unstable prescriptions, or certain retinal diseases may prevent safe implantation. Therefore, screening protects you from avoidable harm and supports better visual results. If EVO ICL is not advised, your doctor will explain safer alternatives.

WHAT HAPPENS AFTER SCREENING

After testing, your surgeon explains your measurements, risk profile, and treatment choices in clear language. Then you receive a personalized recommendation. If you qualify, lens parameters are calculated and surgical planning begins. If you do not qualify, a different vision correction strategy is outlined.